Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Using Medical Illustration to Improve Understanding and Communication of Skin Neglected Tropical Diseases

Butler J. University of Surrey. Faculty of Health and Medical Sciences. 2023;
Download PDF
Publication

Artificial Intelligence in Dermatopathology: updates, strengths, and challenges.

Cazzato G, Rongioletti F. Clinics in dermatology. 2024;
Publication

A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.

Sundar S, Pandey K, Mondal D, et al. PLoS neglected tropical diseases. 2024; 18 (6) : 1-15.
Download PDF
Publication

Effects of cutaneous leishmaniasis on patients' quality of life.

Yizengaw E, Nibret E. BMC infectious diseases. 2024; 24 (1) : 1-5.
Download PDF
Publication

Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens.

Clark J, Kim H, van de Sande W, et al. Medical mycology. 2024; 62 (6) : 1-17.
Download PDF
Publication

Community Feedback on Mass Medicines Administration for Neglected Tropical Diseases in Federal Capital Territory, Abuja, Nigeria.

Amanyi-Enegela J, Badaki J, Alege G, et al. Tropical medicine and infectious disease. 2024; 9 (6) : 1-13.
Download PDF
Publication

Leveraging wastewater-based epidemiology to monitor the spread of neglected tropical diseases in African communities.

Ofori B, Agoha R, Bokoe E, et al. Infectious diseases (London, England). 2024;
Practical material

A Guide to the Clinical Management of Vipera Snakebite in Italy

Riccardo Di Nicola M, Crevani M, Avella I, et al. 2024;
Access resource
Publication

Accessibility of Soil-transmitted Helminthiasis Control Strategies in Selected Indigenous People Communities in the Philippines.

Ladia M, Belizario V, Cubarrubias D, et al. Acta medica Philippina. 2024; 58 (1) : 25-33.
Download PDF
Publication

Meta-analysis and public policy: Reconciling the evidence on deworming

Croke K, Hamory J, Hsu E, et al. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences. 2024; 121 (25) : 1-12.
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • Current page 138
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD